Peer Review History: Role of Tocilizumab in Fighting COVID 19

Editor(s):

(1) Dr. Giuseppe Murdaca, University of Genoa, Italy.

(2) Dr. Rafik Karaman, Professor, College of Pharmacy, Al-Quds University, Palestine.

Reviewers:

(1) Tejeshwari B V, Rajiv Gandhi University of Health Sciences(RGUHS), India.

(2) Olena Yelizarova, State Institution O.M. MarzŅ–eiev Institute For Public Health of The National Academy of Medical Sciences of Ukraine, Ukraine.

(3) Dharmashree Satyarup, Siksha O Anusandhan Deemed To Be University, India.

(4) Blego Sedionoto, Muawarman University, Indonesia.

Additional Reviewers:

(1) Matthew Chak Hin SZETO, United Kingdom.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 7.02/10

Average Peer review marks at publication stage: 9/10

Peer Review History:


Stage 1 | Original Manuscript | File 1 | NA


Stage 2 | Peer review report_1 (Tejeshwari B V, India) | File 1 | NA


Stage 2 | Peer review report_2 (Olena Yelizarova, Ukraine) | File 1 | NA


Stage 2 | Peer review report_3 (Dharmashree Satyarup, India) | File 1 | NA


Stage 2 | Peer review report_4 (Blego Sedionoto, Indonesia) | File 1 | File 2


Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2


Stage 3 | Comment_Editor_1_v1 | File 1 | NA


Stage 3 | Comment_Editor_2_v1 | File 1 | NA